catechin has been researched along with Cockayne-Touraine Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodemer, C; Bourdon-Lanoy, E; Bourrat, E; Chiaverini, C; Fontas, E; Labrèze, C; Lacour, JP; Mazereeuw, J; Roger, C; Vabres, P | 1 |
| Assoumou, A; Bodemer, C; Changotade, SI; de Prost, Y; Fioretti, F; Godeau, G; Guéniche, F; Séguier, S; Senni, K | 1 |
1 trial(s) available for catechin and Cockayne-Touraine Disease
| Article | Year |
|---|---|
Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial.
Topics: Catechin; Cross-Over Studies; Double-Blind Method; Epidermolysis Bullosa Dystrophica; Humans; Metalloendopeptidases; Phenols; United States | 2016 |
1 other study(ies) available for catechin and Cockayne-Touraine Disease
| Article | Year |
|---|---|
Epigallocatechin gallate's protective effect against MMP7 in recessive dystrophic epidermolysis bullosa patients.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blotting, Western; Catechin; Collagen Type VII; Elastic Tissue; Epidermolysis Bullosa Dystrophica; Fibrillin-1; Fibrillins; Genes, Recessive; Humans; Immunologic Techniques; Matrix Metalloproteinase 7; Matrix Metalloproteinase Inhibitors; Microfilament Proteins; Organ Culture Techniques; Protease Inhibitors; Skin; Staining and Labeling; Time Factors; Tissue Distribution | 2007 |